发布求助
文献互助 智能选刊 最新文献

Medicom Conference Report ATS 2023最新文献

筛选
英文 中文
Remarkable results for novel biologic therapy for asthma 新型哮喘生物疗法取得显著成果
Medicom Conference Report ATS 2023 Pub Date : 2023-06-12 DOI: 10.55788/53b454f6
Robert van den Heuvel
{"title":"Remarkable results for novel biologic therapy for asthma","authors":"Robert van den Heuvel","doi":"10.55788/53b454f6","DOIUrl":"https://doi.org/10.55788/53b454f6","url":null,"abstract":"","PeriodicalId":443612,"journal":{"name":"Medicom Conference Report ATS 2023","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124511599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice-changing results for ensifentrine in COPD 依斯芬汀治疗慢性阻塞性肺病的实践改变结果
Medicom Conference Report ATS 2023 Pub Date : 2023-06-12 DOI: 10.55788/b490d047
Robert van den Heuvel
{"title":"Practice-changing results for ensifentrine in COPD","authors":"Robert van den Heuvel","doi":"10.55788/b490d047","DOIUrl":"https://doi.org/10.55788/b490d047","url":null,"abstract":"","PeriodicalId":443612,"journal":{"name":"Medicom Conference Report ATS 2023","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116268049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fewer exacerbations with dupilumab in COPD with type 2 inflammation dupilumab可减少COPD伴2型炎症患者的加重
Medicom Conference Report ATS 2023 Pub Date : 2023-06-12 DOI: 10.55788/b7e00352
Robert van den Heuvel
{"title":"Fewer exacerbations with dupilumab in COPD with type 2 inflammation","authors":"Robert van den Heuvel","doi":"10.55788/b7e00352","DOIUrl":"https://doi.org/10.55788/b7e00352","url":null,"abstract":"","PeriodicalId":443612,"journal":{"name":"Medicom Conference Report ATS 2023","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124661152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH TORREY试验:seralutinib与肺动脉高压肺血管阻力降低相关
Medicom Conference Report ATS 2023 Pub Date : 2023-06-12 DOI: 10.55788/ccddc256
Robert van den Heuvel
{"title":"TORREY trial: seralutinib associated with reduced pulmonary vascular resistance in PAH","authors":"Robert van den Heuvel","doi":"10.55788/ccddc256","DOIUrl":"https://doi.org/10.55788/ccddc256","url":null,"abstract":"","PeriodicalId":443612,"journal":{"name":"Medicom Conference Report ATS 2023","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128092060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Success for fluticasone furoate plus vilanterol in uncontrolled asthma 糠酸氟替卡松加维兰特罗治疗未控制哮喘的成功
Medicom Conference Report ATS 2023 Pub Date : 2023-06-12 DOI: 10.55788/6394c486
Robert van den Heuvel
{"title":"Success for fluticasone furoate plus vilanterol in uncontrolled asthma","authors":"Robert van den Heuvel","doi":"10.55788/6394c486","DOIUrl":"https://doi.org/10.55788/6394c486","url":null,"abstract":"","PeriodicalId":443612,"journal":{"name":"Medicom Conference Report ATS 2023","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121163212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信